183 related articles for article (PubMed ID: 36797416)
1. KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress.
Issa N; Bjeije H; Wilson ER; Krishnan A; Dunuwille WMB; Parsons TM; Zhang CR; Han W; Young AL; Ren Z; Ge K; Wang ES; Weng AP; Cashen A; Spencer DH; Challen GA
Leukemia; 2023 Apr; 37(4):728-740. PubMed ID: 36797416
[TBL] [Abstract][Full Text] [Related]
2. USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia.
Jin Q; Martinez CA; Arcipowski KM; Zhu Y; Gutierrez-Diaz BT; Wang KK; Johnson MR; Volk AG; Wang F; Wu J; Grove C; Wang H; Sokirniy I; Thomas PM; Goo YA; Abshiru NA; Hijiya N; Peirs S; Vandamme N; Berx G; Goosens S; Marshall SA; Rendleman EJ; Takahashi YH; Wang L; Rawat R; Bartom ET; Collings CK; Van Vlierberghe P; Strikoudis A; Kelly S; Ueberheide B; Mantis C; Kandela I; Bourquin JP; Bornhauser B; Serafin V; Bresolin S; Paganin M; Accordi B; Basso G; Kelleher NL; Weinstock J; Kumar S; Crispino JD; Shilatifard A; Ntziachristos P
Clin Cancer Res; 2019 Jan; 25(1):222-239. PubMed ID: 30224337
[TBL] [Abstract][Full Text] [Related]
3. Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.
Kong G; Du J; Liu Y; Meline B; Chang YI; Ranheim EA; Wang J; Zhang J
J Biol Chem; 2013 Jun; 288(25):18219-27. PubMed ID: 23673656
[TBL] [Abstract][Full Text] [Related]
4. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
Sanchez-Martin M; Ferrando A
Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
[TBL] [Abstract][Full Text] [Related]
5. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
Yi J; Shi X; Xuan Z; Wu J
Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
[TBL] [Abstract][Full Text] [Related]
7. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
[TBL] [Abstract][Full Text] [Related]
8. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
Lee SW; Park DY; Kim MY; Kang C
Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
[TBL] [Abstract][Full Text] [Related]
9. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
10. Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesis.
Mallaney C; Ostrander EL; Celik H; Kramer AC; Martens A; Kothari A; Koh WK; Haussler E; Iwamori N; Gontarz P; Zhang B; Challen GA
Leukemia; 2019 Oct; 33(10):2506-2521. PubMed ID: 30936419
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the histone demethylase KDM6B in alcohol dependence is associated with epigenetic regulation of inflammatory signaling pathways.
Johnstone AL; Andrade NS; Barbier E; Khomtchouk BB; Rienas CA; Lowe K; Van Booven DJ; Domi E; Esanov R; Vilca S; Tapocik JD; Rodriguez K; Maryanski D; Keogh MC; Meinhardt MW; Sommer WH; Heilig M; Zeier Z; Wahlestedt C
Addict Biol; 2021 Jan; 26(1):e12816. PubMed ID: 31373129
[TBL] [Abstract][Full Text] [Related]
12. NOTCH1-Induced T-Cell Acute Lymphoblastic Leukemia In Vivo Models.
Campagnari A; Belver L
Methods Mol Biol; 2024; 2773():9-24. PubMed ID: 38236532
[TBL] [Abstract][Full Text] [Related]
13. PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.
Efimenko E; Davé UP; Lebedeva IV; Shen Y; Sanchez-Quintero MJ; Diolaiti D; Kung A; Lannutti BJ; Chen J; Realubit R; Niatsetskaya Z; Ten V; Karan C; Chen X; Califano A; Diacovo TG
Mol Cancer Ther; 2017 Oct; 16(10):2069-2082. PubMed ID: 28716817
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
15. The role of NOTCH1 signaling in T-ALL.
Ferrando AA
Hematology Am Soc Hematol Educ Program; 2009; ():353-61. PubMed ID: 20008221
[TBL] [Abstract][Full Text] [Related]
16. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
[TBL] [Abstract][Full Text] [Related]
17. NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches.
Ma W; Gutierrez A; Goff DJ; Geron I; Sadarangani A; Jamieson CA; Court AC; Shih AY; Jiang Q; Wu CC; Li K; Smith KM; Crews LA; Gibson NW; Deichaite I; Morris SR; Wei P; Carson DA; Look AT; Jamieson CH
PLoS One; 2012; 7(6):e39725. PubMed ID: 22768113
[TBL] [Abstract][Full Text] [Related]
18. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
[TBL] [Abstract][Full Text] [Related]
19. The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
García-Peydró M; Fuentes P; Mosquera M; García-León MJ; Alcain J; Rodríguez A; García de Miguel P; Menéndez P; Weijer K; Spits H; Scadden DT; Cuesta-Mateos C; Muñoz-Calleja C; Sánchez-Madrid F; Toribio ML
J Clin Invest; 2018 Jul; 128(7):2802-2818. PubMed ID: 29781813
[TBL] [Abstract][Full Text] [Related]
20. KDM6B (JMJD3) and its dual role in cancer.
Lagunas-Rangel FA
Biochimie; 2021 May; 184():63-71. PubMed ID: 33581195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
